BENEFIT IN CENTRAL HAEMODYNAMIC PARAMETERS BY ASSOCIATION ANGIOTENSIN II RECEPTOR BLOCKERS AND CANRENONE THERAPY IN HYPERTENSIVE PATIENTS WITH NORMAL KIDNEY FUNCTION

被引：0
|
作者：
Paterno, C. [1 ]
Mastrorocco, N. [2 ]
Goffredo, I. [2 ]
机构：
[1] Cardiovasc Res Ctr, Foggia, Italy
[2] Pugliese Inst Social & Econ Res, Bari, Italy
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000491883.86770.fb
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.13.11
引用
收藏
页码：E194 / E194
页数：1
相关论文
共 50 条
  • [21] Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers
    Takeuchi, K
    Ideishi, M
    Tashiro, T
    Morishige, N
    Yamada, T
    Saku, K
    Urata, H
    HYPERTENSION RESEARCH, 2005, 28 (08) : 639 - 644
  • [22] Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
    Nishida, Yayoi
    Takahashi, Yasuo
    Asai, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 207P - 207P
  • [23] Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
    Yayoi Nishida
    Yasuo Takahashi
    Tomohiro Nakayama
    Satoshi Asai
    Cardiovascular Diabetology, 11
  • [24] Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function
    Bohan, G. R.
    Trofe-Clark, J.
    Fallah, T.
    Norris, M.
    Bloom, R. D.
    Sawinski, D.
    Malat, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 864 - 865
  • [25] HYDROCHLOROTHIAZIDE ASSOCIATED TO ANGIOTENSIN RECEPTOR BLOCKERS TREATMENT CAN DEVELOP ATRIAL FIBRILLATION ACCORDING CENTRAL HEAMODYNAMIC PARAMETERS IN HYPERTENSIVE PATIENTS
    Marchioli, C. A. Paterno
    JOURNAL OF HYPERTENSION, 2018, 36 : E161 - E161
  • [26] Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease
    Ahn, Shin Young
    Kim, Dong Ki
    Han, Seung Seok
    Park, Jung Hwan
    Shin, Sung Joon
    Lee, Sang Ho
    Choi, Bum Soon
    Lim, Chun Soo
    Kim, Suhnggwon
    Chin, Ho Jun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2018, 37 (01) : 49 - 58
  • [27] Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series
    Lee, Su Jin
    Kim, Taehwa
    Cho, Woo Hyun
    Jeon, Doosoo
    Lim, Seungjin
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2021, 2021
  • [28] Potential effects of angiotensin II receptor blockers on glucose tolerance and adiponectin levels in hypertensive patients
    Makita, Shinji
    Abiko, Akihiko
    Naganuma, Yujirou
    Moriai, Yoshiteru
    Nakamura, Motoyuki
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (04) : 317 - 318
  • [29] Potential Effects of Angiotensin II Receptor Blockers on Glucose Tolerance and Adiponectin Levels in Hypertensive Patients
    Shinji Makita
    Akihiko Abiko
    Yujirou Naganuma
    Yoshiteru Moriai
    Motoyuki Nakamura
    Cardiovascular Drugs and Therapy, 2007, 21 : 317 - 318
  • [30] Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic
    Littlejohn, TW
    BLOOD PRESSURE MONITORING, 2001, 6 : S15 - S21
12345